Psychiatry & Neurology Doctors in New Lisbon, WI Accepting Medicare
1 Psychiatry & Neurology doctors found. Showing 1 - 1
 Bret Reynolds, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2000 Progress Road, New Lisbon Correctional Institute-health Services Unit, New Lisbon, WI 53950 Phone: 608-562-6400 |
News Archive
Report provides two distinct views of behavioral healthcare delivery
Behavioral healthcare systems are playing a major role in responding to the needs of the millions of Americans of all ages who experience psychiatric and substance use conditions each year, according to the latest annual survey from the National Association of Psychiatric Health Systems (NAPHS) released today.
Scarab Genomics launches White Glove IS Detection Kit
Scarab Genomics has now launched the White Glove IS Detection Kit to test for the presence of transposable Insertion Sequence (IS) elements in a DNA of interest. Numerous IS elements are naturally present in the genomes of E. coli strains commonly used for protein and plasmid production, but are not present in the Scarab Genomics Clean Genome® strains.
HealthCare Appraisers opens new office in Wayne, Pennsylvania
HealthCare Appraisers, Inc. (HAI) announced today that the firm has opened a new office in the Philadelphia area. The new office, in Wayne, Pennsylvania, is part of HAI's continued office expansion to provide fair market value (FMV) analysis and valuation services to the healthcare and life sciences industries nationwide.
An already-changing insurance market may face more transformation
The Wall Street Journal: "Insurers are increasingly setting up brick-and-mortar retail stores that peddle individual and sometimes small-group health plans, with companies including Humana Inc., Aetna Inc. and Health Net Inc. so far trying the concept. Blue Cross Blue Shield plans in Pennsylvania and South Carolina say they've had good results from shops, while Blue Cross & Blue Shield of Florida Inc. plans to add five more locations after the success of its existing two."
immatics initiates IMA901 Phase III trial in renal cell carcinoma
igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.
› Verified 3 days ago